harmaline


dihydroharmine; harmaline; 7-methoxy-1-methyl-3,4-dihydro-2H-pyrido[3,4-β]indole
Links:🌍 Wikipedia, 📏 NIST, 🕷 ChemSpider, ⚗️ ChemSynthesis, 📖 PubMed
MeSH:Central Nervous System Agents; Central Nervous System Stimulants; Enzyme Inhibitors
CAS RN:[304-21-2]
Formula:C13H14N2O; 214.27 g/mol
InChiKey:RERZNCLIYCABFS-UHFFFAOYSA-N
SMILES:COc1ccc2c3CCN=C(C)c3[nH]c2c1
Molecular structure of harmaline
Pharmaceutical use:antiparkinsonian; CNS-stimulant
Toxicology (LD50):101.0 mg/Kg (cat, sc); 32.0 mg/Kg(dog, sc); 250 mg/Kg(frog, sc); 101.0 mg/Kg(guinea~pig, sc); 101.0 mg/Kg(rabbit, sc); 120 mg/Kg(rat, sc)
Melting point:230 °C

Isomers

harmaline
Molecular structure of harmaline
N-(4-methoxyphenyl)benzene-1,4-diamine
Molecular structure of N-(4-methoxyphenyl)benzene-1,4-diamine
2-methoxy-N4-phenyl-1,4-phenylenediamine
Molecular structure of 2-methoxy-N4-phenyl-1,4-phenylenediamine
3-phenyl-4-butyl-5-pyrazolone
Molecular structure of 3-phenyl-4-butyl-5-pyrazolone
phenyramidol
Molecular structure of phenyramidol
7,8,9,10-tetrahydroazepino[2,1-β]quinazolin-12(6~H)-one
Molecular structure of 7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one
velnacrine
Molecular structure of velnacrine